SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number 0-19803
NOTIFICATION OF LATE FILING
[ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR
For Period Ended: June 30, 1996
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
This notification relates to all Items within the Form 10-Q.
PART I. REGISTRANT INFORMATION
Full name of registrant: ALLEGIANT PHYSICIAN SERVICES, INC.
Former name if applicable: N/A
Address of principal executive office: 500 Northridge Road, Suite 500
City, State and Zip Code: Atlanta, Georgia 30350
PART II. RULE 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed.
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, 20-F, 11-K or Form N- SAR, or portion thereof will be filed
on or before the 15th calendar day following the prescribed due date;
or the subject quarterly report or transition report on Form 10-Q, or
portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III. NARRATIVE
Due to the timing of certain transactions and events, the Company is not
able to timely file its Form 10-Q for the period ending June 30, 1996 without
unreasonable effort or expense. The Company currently sold its contract
anesthesia business on June 1, 1996, which represents approximately 95% of the
Company's business. The transaction is subject to the Company obtaining
shareholder approval, which is scheduled to take place in September 1996. The
Company is diligently completing its financial statement and related footnotes
for proper presentation and disclosure.
PART IV. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Timothy L. Powers (770) 643-5633
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[X] Yes [ ] No
The Company expects to record a loss of approximately $2.5 to $3.5 million
for the three months ending June 30, 1996, compared to income of $537,000 for
the three months ending June 30, 1995. The Company is diligently working to
compile the financial data for proper presentation and disclosure. Due to the
transaction describe above the Company has not completed its quarterly financial
statements for the quarter ending June 30, 1996, reported on Form 10-Q.
ALLEGIANT PHYSICIAN SERVICES, INC.
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: August 14, 1996 By: /s/ Timothy L. Powers
------------------------
Timothy L. Powers
Executive Vice President and Chief Financial Officer
